Stock Groups

Is G Medical Innovations Holdings a Winner in the Medical Device Industry? -Breaking

by Mike Robinson

[ad_1]

© Reuters. G Medical Innovations Holdings: A Winner in Medical Device Industry?

G Medical shares (GMVD), which have lost 18.4% over the last three months, has shown weak momentum. And given the company’s weak bottom-line, the question is, will the stock be able to rebound soon? Continue reading to learn more. G Medical Innovations Holdings Ltd, an Israel-based company at the commercial stage of healthcare, is currently developing next-generation mobile medical and telemedicine services in America, China, Israel, and other countries.

Shares of GMVD have slumped 18.4% in price over the past three months to close yesterday’s trading session at $2.30. The stock currently trades above its 50-day moving mean of $2.26 but below its 200 day moving average, which is $2.83.

With an increase in demand for services and products related to healthcare, the global healthcare sector is flourishing. An aging population is also driving the industry’s growth. With increasing demand and ongoing medical innovations and advances, industry growth is predicted to continue. However, GMVD’s bottom-line has yet to reflect the industry tailwinds.

Continue reading on StockNews

Disclaimer Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media does not accept any liability for trade losses you may incur due to the use of these data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts, buy/sell signal, and quotes. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.



[ad_2]